EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

No Effect of Ppm1d -Mutant Clonal Hematopoiesis on Atherosclerosis Development in Mice

Marta Amorós-Pérez iD, María A Zuriaga, Virginia Zorita, Beatriz L Ramos-Neble, Nuria Matesanz, Clara Plötner iD, Milena Di Carli, Eline L C Mol iD, Rosa Moro, Diego Cuevas, Vicente Andrés iD, José J Fuster iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2026

DOI: 10.1161/atvbaha.125.323734 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026. Verfasst von Marta Amorós-Pérez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain (M.A.-P., M.A.Z., V.Z., B.L.R.-N., N.M., C.P., M.D.C., E.L.C.M.,…. Hauptthemen laut MEDLINE: Protein Phosphatase 2C, Atherosclerosis, Clonal Hematopoiesis, Mutation. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Clonal hematopoiesis driven by somatic mutations is an emerging cardiovascular risk factor, and the DNA damage response gene PPM1D is among the most frequently mutated genes. Mutations in PPM1D are enriched in cancer patients and survivors, where cytotoxic therapies promote the expansion of mutant clones, a condition termed therapy-related clonal hematopoiesis. Although PPM1D -mutant clonal hematopoiesis has been associated with increased risk and poorer prognosis of atherosclerotic cardiovascular disease in humans, it remains unclear whether these mutations, or their expansion under cytotoxic stress, causally contribute to atherosclerosis. METHODS: We modeled PPM1D -mutant clonal hematopoiesis in Ldlr −/− mice through bone marrow transplantation strategies. Conventional transplantation approaches were used to generate mice with complete or partial hematopoietic reconstitution by cells carrying monoallelic or biallelic gain-of-function Ppm1d R451X mutations. To mimic therapy-related clonal hematopoiesis, we used a nonconditioned adoptive transfer model in which a small fraction of mutant hematopoietic cells was introduced into recipients, followed by fractionated low-dose γ-radiation to promote clonal expansion. All mice were fed a Western diet to induce atherosclerosis. Clonal dynamics, plaque size and characteristics, and macrophage functions were evaluated using flow cytometry, histopathology, and in vitro assays. RESULTS: Ppm1d -mutant cells expanded in blood and bone marrow after low-dose radiation, but not in nonirradiated mice. Across all transplantation strategies, Ppm1d mutations did not affect plasma cholesterol, atherosclerotic plaque size, or composition. In vitro, mutant macrophages showed no alterations in proliferation, cytokine expression, or cholesterol handling, although apoptosis in response to genotoxic stress was modestly reduced (≈20%). CONCLUSIONS: Ppm1d -mutant hematopoietic cells expand predominantly under genotoxic stress and do not promote atherosclerosis in mice under the conditions tested. These findings raise the possibility that the association of PPM1D mutations with atherosclerotic cardiovascular disease may, at least in part, reflect exposure to DNA damage response–activating stressors that independently promote clonal expansion and atherosclerosis, rather than direct causality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Phosphatase 2CAtherosclerosisClonal HematopoiesisMutationAortic DiseasesAortaAnimalsDisease Models, AnimalBone Marrow TransplantationMice, Inbred C57BLPhenotypeReceptors, LDLMice, KnockoutPlaque, AtheroscleroticMacrophagesMaleGenetic Predisposition to DiseaseCell ProliferationMice

Stichwörter der Autor:innen

atherosclerosiscardiovascular diseasesclonal hematopoiesismacrophagesradiation

Substanzen

Protein Phosphatase 2CPpm1d protein, mouseReceptors, LDL

Autor:innen und Institutionen

  • Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain (M.A.-P., M.A.Z., V.Z., B.L.R.-N., N.M., C.P., M.D.C., E.L.C.M., R.M., D.C., V.A., J.J.F.).
  • Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid. Spain (M.A.-P., V.A., J.J.F.).
  • Now with Institute of Neuroanatomy and Cell Biology, Hannover Medical School, Germany (C.P.).
  • Now with Department of Anatomy & Embryology and Cardiology, Leiden University Medical Center (LUMC), the Netherlands (E.L.C.M.).

ORCID-Profile: Marta Amorós-Pérez, Clara Plötner, Eline L C Mol, Vicente Andrés, José J Fuster

Zitieren

APA

Amorós-Pérez, M., Zuriaga, M. A., Zorita, V., Ramos-Neble, B. L., Matesanz, N., Plötner, C., Di Carli, M., Mol, E. L. C., Moro, R., Cuevas, D., Andrés, V., & Fuster, J. J. (2026). No Effect of Ppm1d -Mutant Clonal Hematopoiesis on Atherosclerosis Development in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.125.323734

Vancouver

Amorós-Pérez M, Zuriaga MA, Zorita V, Ramos-Neble BL, Matesanz N, Plötner C, et al. No Effect of Ppm1d -Mutant Clonal Hematopoiesis on Atherosclerosis Development in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.125.323734

BibTeX
@article{AmorsPrez2026,
  author = {Amorós-Pérez, Marta and Zuriaga, María A and Zorita, Virginia and Ramos-Neble, Beatriz L and Matesanz, Nuria and Plötner, Clara and Di Carli, Milena and Mol, Eline L C and Moro, Rosa and Cuevas, Diego and Andrés, Vicente and Fuster, José J},
  title = {No Effect of Ppm1d -Mutant Clonal Hematopoiesis on Atherosclerosis Development in Mice},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2026},
  doi = {10.1161/atvbaha.125.323734}
}
Kostenlos starten →